Emily M. Pang
- Hematology top 5%
- Molecular Biology
- Genetics top 10%
- Oncology
- Rheumatology
- Co-authors
- Xiaoyan JiangAshley RingroseYouwen ZhouAndrew P. WengAnn LinXiaojiang LiIrene LiAllen Eaves
- Topics
- Chronic Myeloid Leukemia Treatments (5 papers)Chronic Lymphocytic Leukemia Research (4 papers)Childhood Cancer Survivors' Quality of Life (4 papers)
- Cited by
- HematologyGeneticsInternal Medicine
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Emily M. Pang
19 papers receiving 536 citations
Peers
Comparison fields: 5 of 88
- Hematology 262
- Molecular Biology 150
- Genetics 135
- Oncology 73
- Rheumatology 61
Countries citing papers authored by Emily M. Pang
This map shows the geographic impact of Emily M. Pang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily M. Pang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily M. Pang more than expected).
Fields of papers citing papers by Emily M. Pang
This network shows the impact of papers produced by Emily M. Pang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily M. Pang. The network helps show where Emily M. Pang may publish in the future.
Co-authorship network of co-authors of Emily M. Pang
This figure shows the co-authorship network connecting the top 25 collaborators of Emily M. Pang. A scholar is included among the top collaborators of Emily M. Pang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily M. Pang. Emily M. Pang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 7 | |
| 4 | 5 | |
| 5 | 1 | |
| 6 | 2 | |
| 7 | 4 | |
| 8 | 8 | |
| 9 | 14 | |
| 10 | 4 | |
| 11 | 34 | |
| 12 | 12 | |
| 13 | 46 | |
| 14 | 59 | |
| 15 | 26 | |
| 16 | 104 | |
| 17 | 168 | |
| 18 | 12 | |
| 19 | 2 | |
| 20 | 35 |
About Emily M. Pang
Emily M. Pang is a scholar working on Hematology, Health Information Management and Genetics, having authored 20 papers that have together received 544 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (5 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Childhood Cancer Survivors' Quality of Life (4 papers). The work is most often cited by research in Hematology (262 citations), Genetics (135 citations) and Internal Medicine (28 citations). Emily M. Pang has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Xiaoyan Jiang, Ashley Ringrose, Youwen Zhou, Andrew P. Weng, Ann Lin, Xiaojiang Li, Irene Li, Allen Eaves, Connie J. Eaves and Tessa L. Holyoake. Their work appears in journals such as Journal of Clinical Oncology, Blood and Biophysical Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.